233 related articles for article (PubMed ID: 32375811)
1. Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain.
Donninelli G; Saraf-Sinik I; Mazziotti V; Capone A; Grasso MG; Battistini L; Reynolds R; Magliozzi R; Volpe E
J Neuroinflammation; 2020 May; 17(1):149. PubMed ID: 32375811
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
3. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Hamamcioglu K; Reder AT
Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
[TBL] [Abstract][Full Text] [Related]
4. T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.
Ruocco G; Rossi S; Motta C; Macchiarulo G; Barbieri F; De Bardi M; Borsellino G; Finardi A; Grasso MG; Ruggieri S; Gasperini C; Furlan R; Centonze D; Battistini L; Volpe E
Clin Sci (Lond); 2015 Aug; 129(4):291-303. PubMed ID: 25700150
[TBL] [Abstract][Full Text] [Related]
5. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis.
Mack CL; Vanderlugt-Castaneda CL; Neville KL; Miller SD
J Neuroimmunol; 2003 Nov; 144(1-2):68-79. PubMed ID: 14597100
[TBL] [Abstract][Full Text] [Related]
6. Interleukin (IL)-31 activates signal transducer and activator of transcription (STAT)-1, STAT-5 and extracellular signal-regulated kinase 1/2 and down-regulates IL-12p40 production in activated human macrophages.
Kasraie S; Niebuhr M; Werfel T
Allergy; 2013 Jun; 68(6):739-47. PubMed ID: 23621408
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients.
Nguyen LT; Ramanathan M; Weinstock-Guttman B; Baier M; Brownscheidle C; Jacobs LD
J Neurol Sci; 2003 May; 209(1-2):93-9. PubMed ID: 12686409
[TBL] [Abstract][Full Text] [Related]
8. IL-9 signaling affects central nervous system resident cells during inflammatory stimuli.
Ding X; Cao F; Cui L; Ciric B; Zhang GX; Rostami A
Exp Mol Pathol; 2015 Dec; 99(3):570-4. PubMed ID: 26216406
[TBL] [Abstract][Full Text] [Related]
9. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
Killestein J; Den Drijver BF; Van der Graaff WL; Uitdehaag BM; Polman CH; Van Lier RA
Mult Scler; 2001 Jun; 7(3):145-50. PubMed ID: 11475436
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients.
Guggino G; Lo Pizzo M; Di Liberto D; Rizzo A; Cipriani P; Ruscitti P; Candore G; Gambino CM; Sireci G; Dieli F; Giacomelli R; Triolo G; Ciccia F
Clin Exp Immunol; 2017 Nov; 190(2):208-216. PubMed ID: 28681919
[TBL] [Abstract][Full Text] [Related]
11. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
12. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.
Hulshof S; Montagne L; De Groot CJ; Van Der Valk P
Glia; 2002 Apr; 38(1):24-35. PubMed ID: 11921201
[TBL] [Abstract][Full Text] [Related]
13. Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MS.
Balashov KE; Comabella M; Ohashi T; Khoury SJ; Weiner HL
Neurology; 2000 Jul; 55(2):192-8. PubMed ID: 10908889
[TBL] [Abstract][Full Text] [Related]
14. IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysaccharide-stimulated human monocytes through TGF-beta.
Pilette C; Ouadrhiri Y; Van Snick J; Renauld JC; Staquet P; Vaerman JP; Sibille Y
J Immunol; 2002 Apr; 168(8):4103-11. PubMed ID: 11937570
[TBL] [Abstract][Full Text] [Related]
15. Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
Sénécal V; Deblois G; Beauseigle D; Schneider R; Brandenburg J; Newcombe J; Moore CS; Prat A; Antel J; Arbour N
Glia; 2016 Apr; 64(4):553-69. PubMed ID: 26649511
[TBL] [Abstract][Full Text] [Related]
16. Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains.
Zhang Z; Zhang ZY; Schittenhelm J; Wu Y; Meyermann R; Schluesener HJ
J Neuroimmunol; 2011 Aug; 237(1-2):73-9. PubMed ID: 21737148
[TBL] [Abstract][Full Text] [Related]
17. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
Balashov KE; Rottman JB; Weiner HL; Hancock WW
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
[TBL] [Abstract][Full Text] [Related]
18. GM-CSF promotes migration of human monocytes across the blood brain barrier.
Vogel DY; Kooij G; Heijnen PD; Breur M; Peferoen LA; van der Valk P; de Vries HE; Amor S; Dijkstra CD
Eur J Immunol; 2015 Jun; 45(6):1808-19. PubMed ID: 25756873
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis.
Kadowaki A; Saga R; Lin Y; Sato W; Yamamura T
Brain; 2019 Apr; 142(4):916-931. PubMed ID: 30770703
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
